Chemosensitization is not associated with improved adjuvant radiation outcomes for cutaneous squamous cell carcinoma: A dual-center retrospective cohort study - 18/12/25
Doi : 10.1016/j.jaad.2025.09.015
Emily E. Granger, MD a, Emily Y. Kim, MD b, Nina A. Ran, MD, MS, MPH c, Karina Brito, BS d, David M. Wang, MD, MPH c, Ann W. Silk, MD d, Danielle N. Margalit, MD e, Roy B. Tishler, MD e, Jonathan D. Schoenfeld, MD, MPH e, Shauna Campbell, DO f, Allison Vidimos, MD g, Daniel McGrail, PhD h, Shlomo Koyfman, MD f, Emily S. Ruiz, MD, MPH c, ⁎ 
a Department of Dermatology, Duke University, Durham, North Carolina
b Department of Dermatology, University of Michigan Hospital, Ann Arbor, Michigan
c Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts
d Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
e Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts
f Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio
g Department of Dermatology, Cleveland Clinic, Cleveland, Ohio
h Center for Immunotherapy and Precision Immuno-Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio
∗Correspondence to: Emily S. Ruiz, MD, MPH, Department of Dermatology, Brigham and Women's Hospital, 1153 Centre St, Suite 4J, Boston, MA 02130Department of DermatologyBrigham and Women's Hospital1153 Centre StSuite 4JBostonMA02130
Key words : adjuvant radiation therapy, chemoradiation, cutaneous oncology, cutaneous squamous cell carcinoma, nonmelanoma skin cancer, systemic therapy
Plan
| Drs Granger, Kim, Koyfman, and Ruiz contributed equally. |
|
| Funding sources: None. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Reviewed and approved by institutional review boards at Brigham and Women's Hospital/Dana-Farber Cancer Institute (IRB:2018P002653) and Cleveland Clinic Foundation (IRB:17-123). |
© 2025
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 94 - N° 1
P. 284-287 - janvier 2026 Retour au numéro
Article précédent
- Risk of cutaneous T-cell lymphoma in patients with autoimmune diseases
- Bethany Brumbaugh, Mike Westmeijer, Beatrix Thompson, Allison Holt, Joseph Ebriani, Kevin Sheng-Kai Ma, Steven T. Chen
- Diagnostic accuracy of ChatGPT in dermatology: A meta-analysis of textual versus visual prompts
- Ryan Chen, Daniel H. Nguyen, Kevin D. Fettel, William J. Nahm, Goranit Sakunchotpanit, Sarah S. Lee, Krithika Nayudu, Vinod E. Nambudiri
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?